SpeedBird
Soft Tissue Biopsy (Breast)
CommercialActive
Key Facts
About TransMed7
TransMed7 is a medical device innovator with a patented 'Zero5' forward-coring biopsy technology designed to overcome limitations of traditional side-cutting needles. Its platform enables single-insertion, multiple-collection biopsies with minimal tissue damage, targeting applications in breast health, lymph nodes, thyroid, and other soft tissues. The company is privately held, FDA-cleared for some devices, and operates with a philosophy of patient-first, globally accessible healthcare solutions. Its pipeline includes several handheld and stereotactic devices under brands like SpeedBird, Concorde, and Cardinal.
View full company profile